Back to Search
Start Over
Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy
- Source :
- Rheumatology (Oxford, England)
- Publication Year :
- 2021
- Subjects :
- Adenosine Triphosphatases
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
biology
business.industry
MEDLINE
COVID-19
Dermatomyositis
medicine.disease
Dermatology
Letter to the Editor (Case report)
DNA-Binding Proteins
Rheumatology
biology.protein
Medicine
Humans
Pharmacology (medical)
Antibody
business
AcademicSubjects/MED00360
Autoantibodies
Subjects
Details
- ISSN :
- 14620332
- Volume :
- 61
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- Rheumatology (Oxford, England)
- Accession number :
- edsair.doi.dedup.....ed8a403d4fa2edf934a00ee9411a6fcb